When was Akkure founded?

Akkure was founded in 2016 and raised its 1st funding round 5 years after it was founded.

Where is Akkure located?

Akkure is headquartered in Dublin, Ireland.

How many employees does Akkure have?

As of Dec 31, 2024, the latest employee count at Akkure is 1.

Is Akkure a funded company?

Akkure is a funded company, having raised a total of $3.37M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2021.

When was the latest funding round of Akkure?

Akkure's latest funding was a $***** Grant (prize money) round on Nov 22, 2022, with participation from 1 investor.

Where does Akkure rank among its competitors?

Akkure ranks 124th amongst 710 active competitors, of which 85 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Ryght, which secured an undisclosed amount in Dec, 2025.

Who are the top competitors of Akkure?

Akkure's top competitors include Unlearn, Strand Life Sciences and Hexagon Bio. Among them, Ryght secured the most recent funding round in December, 2025.

Akkure - 2026 Company Profile, Team, Funding & Competitors

Company Details

Akkure is an online platform for genomics data analytics. The platform enables the user to control, manage data or provide rewards for sharing data. It also enables researchers to connect with organizations to order DNA test kits for genomics sequencing, receive results, and analyze genomics data. The company uses blockchain-based technology in order to share and manage research data analytics.

Key Metrics

Founded Year

2016

Location

Dublin, Ireland

Stage

Seed

Total Funding

$3.37M in 3 rounds

Latest Funding Round

Grant (prize money), Nov 22, 2022, $*****

Investors

Enterprise Ireland & 1 more

Ranked

124^th among 710 active competitors

Employee Count

1 as on Dec 31, 2024

Similar Companies

Unlearn & 877 more

View Akkure's full profile

Akkure has raised a total funding of $3.37M over 3 rounds. Its first funding round was on 2021. Its latest funding round was a Grant (prize money) round on Nov 22, 2022 for $*****. 1 investor participated in its latest round. Akkure has 2 institutional investors.

Here is the list of recent funding rounds of Akkure:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 22, 2022	9692617	Grant (prize money)	5911819	9062142	6885244	6026952
Jan 29, 2021	7516275	Seed	9820977	5814164	5913358	2252602
2021	3589	Seed	1499	9332	Enterprise Ireland	8709

Access funding benchmarks and valuations. Sign up today!

View details of Akkure's funding rounds and investors

The founders of Akkure are Oran Rigby and Amy Hollingworth.

Here are the details of Akkure's key team members:

Oran Rigby: Co-Founder of Akkure.
Amy Hollingworth: Co-Founder of Akkure.

View details of Akkure's Founder profiles and Board Members

Akkure's employee count trend

Akkure has 1 employees as of Dec 24. Here is Akkure's employee count trend over the years:

Uncover Akkure's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Akkure include Unlearn, Strand Life Sciences and Hexagon Bio. Here is the list of Top 10 competitors of Akkure, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Unlearn 2017, San Francisco (United States), Series C	Developer of an AI platform for clinical trial design and analysis	$135M	Altimeter Capital, Insight Partners & 14 others	65/100
2nd	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, Quadria Capital & 91 others	64/100
3rd	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, 8VC & 10 others	63/100
4th	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	61/100
5th	ONCOHOST 2017, Binyamina Giv at Ada (Israel), Series C	AI-based oncology therapy plan solution for professionals	$43M	OurCrowd, ALIVE & 5 others	61/100
6th	Genewiz 1999, South Plainfield (United States), Acquired	Provider of a wide range of genomic services for the life sciences industry	-	Kenson Ventures, Orbimed & 5 others	59/100
7th	deCODE Genetics 1996, Reykjavik (Iceland), Acquired	Provider of a bioinformatics platform for genetic analysis	-	Polaris Partners, Tekla Capital Management ... & 10 others	59/100
8th	Ryght 2023, Anaheim (United States), Series A	Generative AI platform focused on biopharma smart biomedical data	$8.57M	Virtue, Foothill Ventures & 3 others	55/100
9th	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Fusion Capital, Sequoia Capital China & 15 others	54/100
10th	Source BioScience 1903, Nottingham (United Kingdom), Acquired	Provider of multiple genomic services	-	HPE	54/100
124th	Akkure 2016, Dublin (Ireland), Seed	Provider of a blockchain technology based online platform for genomic data analytics	$3.37M	Enterprise Ireland, Digital Transformation Innovation Fund ... Read more	32/100